Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
67
ARTV Quote, Financials, Valuation and Earnings
Last price:
$5.74
Seasonality move
:
-67.7%
Day range:
$5.48 - $5.90
52-week range:
$1.47 - $7.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
46.79x
P/B ratio:
1.08x
Volume:
109.5K
Avg. volume:
153.1K
1-year change:
6.53%
Market cap:
$140.2M
Revenue:
$251K
EPS (TTM):
-$3.25
Earnings Data
Next earnings date for ARTV
--
Most recent earnings per share
-$0.88
Missed by $0.08
(Sep 30/2025)
Consensus Estimate
-$0.80
(Sep 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ARTV Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2025 | Q4 | -- | -- | -- | -$0.80 | -- |
| 09/30/2025 | Q3 | -- | -- | -$0.88 | -$0.80 | -$0.08 |
| 08/07/2025 | Q2 | -- | -- | -$0.87 | -$0.77 | -$0.10 |
| 05/08/2025 | Q1 | -- | -- | -$0.83 | -$0.62 | -$0.21 |
| 03/24/2025 | Q4 | $50K | -- | -$0.66 | -$0.58 | -$0.08 |
| 11/12/2024 | Q3 | $75K | -- | -$0.92 | -$0.64 | -$0.29 |
| 08/29/2024 | Q2 | $75K | -- | -$0.62 | -$1.59 | $0.97 |
| 03/31/2024 | Q1 | -- | $251K | -$1.49 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.95 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.69 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.65 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$2.43 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.34 | -- | -- |
Artiva Biotherapeutics, Inc. Earnings Questions
-
How Much did Artiva Biotherapeutics, Inc. Generate in Revenue Last Quarter?
Artiva Biotherapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Artiva Biotherapeutics, Inc. Beat Earnings Last Quarter?
Artiva Biotherapeutics, Inc. announced earnings per share of -$0.88 which represents a miss of analyst forecast a -$0.80 per share.
-
Is Artiva Biotherapeutics, Inc. Profitable?
Artiva Biotherapeutics, Inc. reported -$662K that represents -$0.03 per share over the last quarter.
-
What is the Analyst Consensus for Artiva Biotherapeutics, Inc. EPS Next Year?
Artiva Biotherapeutics, Inc.'s earnings are forecast to decrease from -$2.69 per share to -$3.09 per share next year representing a decrease of -14.82%.
-
When is Artiva Biotherapeutics, Inc.'s Earnings Date?
Currently, Artiva Biotherapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on June 9, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
47
GSIW alert for Mar 10
Garden Stage Ltd. [GSIW] is down 17.65% over the past day.
Buy
68
XENE alert for Mar 10
Xenon Pharmaceuticals, Inc. [XENE] is down 4.05% over the past day.
Buy
67
BNAI alert for Mar 10
Brand Engagement Network, Inc. [BNAI] is down 12.49% over the past day.
